SCHEMBL4740747

SCHEMBL4740747

NCCc1ccc(NC(=O)c2ccc(Cl)nc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.64
SMN1; SMN2 Q16637 3/20 0.64
MEN1 O00255 2/20 0.61
KMT2A Q03164 2/20 0.61
ALDH1A1 P00352 1/20 0.61
LMNA P02545 1/20 0.61
KCNQ3 O43525 7/20 0.56
KCNQ2 O43526 7/20 0.56
KCNE1 P15382 6/20 0.56
KCNQ1 P51787 6/20 0.56
MAPT P10636 3/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
BACE1 P56817 1/20 0.55
NPC1 O15118 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4177141 0.89 RAB9A (0.68) RAB9ASMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL24891741 0.82 MEN1 (0.63) RAB9ASMN1; SMN2MEN1KMT2ALMNA
SCHEMBL28049871 0.82 L3MBTL1 (0.72) RAB9ASMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL1986996 0.81 KCNQ3 (0.82) RAB9ASMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL5215207 0.81 KCNQ3 (0.81) RAB9ASMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL3313800 0.80 RAB9A (0.75) RAB9ASMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL28049980 0.79 RAB9A (0.57) RAB9ASMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL2801974 0.79 KCNQ3 (0.85) RAB9ASMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL8361559 0.79 RAB9A (1.00) RAB9ASMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL2306301 0.78 RAB9A (0.76) RAB9ASMN1; SMN2MEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008086462-A2 AMINO-SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF β-CANTENIN/TCF-4 PATHWAY AND CANCER TREATMENT AGENTS WYETH (US) 2008-07-17 WO disclosed